You are here

Paediatric Tetanus in Rural Zambia: A Case Study

Journal Name:

Publication Year:

Abstract (2. Language): 
Background: Health care professionals from industrialized nations often travel to work in developing countries as volunteers during natural disasters, as part of short-term medical missions, or to work as members of armed forces and non-governmental organizations. When providing direct patient care, these clinicians are more likely to encounter vaccine-preventable diseases that they may rarely observe in a developed country. In addition, many children who do not have adequate vaccine coverage enter developed nations through international adoption processes or as political refugees. Additionally, despite much debunking of immunization myths, there is a sizable community of parents who choose to withhold immunizations from their children because of fear of unproven side effects. Methods and Results: This case study highlights a case of a globally-common, vaccine-preventable disease (tetanus), which rarely occurs in developed nations but is more common in Africa and Asia. Diagnosis and management of a 7-year old boy is presented with differential diagnoses and adaptation of optimal disease management within the context of an undeveloped nation. All cases of tetanus are diagnosed clinically, with laboratory testing used to rule out other causes of neurological impairment. The management of acute tetanus infection includes vaccination, antibiotics, immunoglobulin or antitoxin, and nutritional support. Even with optimal treatment, tetanus infection has a high fatality rate and requires prompt recognition for best possible outcomes. Conclusion: Educating caregivers about the importance and safety of immunizations and maintaining the appropriate vaccination schedule is vital to control these preventable diseases.
15-20

REFERENCES

References: 

1. Afshar, M., Raju, M., Ansell, D., & Bleck, T. (2011). Narrative review: Tetanus-a health threat after natural disasters in developing countries. Annals of Internal Medicine, 154(5), 329-335.
2. Bleck T.P., & Brauner J.S. (2004). Tetanus. In: Scheld W.M., Whitley R.J., Durack D.T. (Eds.) Infections of the central nervous system (3rd ed., pp. 629-623). Philadelphia, PA: Lippincott-Raven Publishers.
3. Campbell, J. I., Yen, L. T. M., Loan, H. T., Diep, T. S., Nga, T. T. T., Van Minh Hoang, N., Son,L. T., et al. (2009).
Microbiologic characterization and antimicrobial susceptibility of Clostridium tetani isolated from wounds of patients with clinically diagnosed tetanus. American Journal of Tropical Medicine and Hygiene, 80(5), 827-831.
4. CDC (2006). Facts about Strychnine. Retrieved from http://www.bt.cdc.gov/agent/strychnine/basics/facts.asp
5. CDC (2011). Tetanus Surveillance- United States, 2001-2008. Morbidity and Mortality Weekly Report, 60(12) 365-69. Retrieved from http://cdc.gov/mmwr/preview/mmwrhtml/mm6012a1.htm?s_cid=mm6012a1_w
6. Grunau, B. and Olson, J. (2010). An interesting case of pediatric tetanus. Canadian Journal of Emergency Medicine;12(1), 69-72.
7. Howard, C., & John, C. (2011). International adoption. In: CDC Health Information for International Travel, The Yellow Book, 2012. Oxford New York: Oxford University Press. Retrieved 09/25/11 from http://wwwnc.cdc.gov/yellowbook/2012/chapter-7-international-travel-infa....
8. Thwaites, C.L., and Yen, L (2008). Tetanus. In: Mason’s Tropical Diseases (21st ed., pp 1113-19). Philadelphia: W.B. Saunders, Elsevier Limited.
9. Thwaites, C. L., Yen, L. M., Glover, C., Tuan, P. Q., Nga, N. T. N., Parry, J., Loan, H. T., Bethell, D., Day, N. P. J., White, N. J., Soni, N., & Farrar, J. J. (2006), Predicting the clinical outcome of tetanus: the tetanus severity score. Tropical Medicine & International Health, 11: 279–287. doi: 10.1111/j.1365-3156.2006.01562.x
10. World Health Organization. (n.d.). Immunization surveillance and monitoring. Retrieved from http://www.who.int/immunization_monitoring/diseases/en/
11. World Health Organization. (2006). Tetanus vaccine: WHO position paper. World Epidemiological Record. 81, 197–208.

Thank you for copying data from http://www.arastirmax.com